Diabetes Products and Issues

Our diabetes team handles worldwide litigation related to diabetes products and medications and conducts risk assessments related to such products. Recognizing that our clients need to protect their businesses, including the viability of their products in the marketplace, King & Spalding litigators work together with our FDA & Life Sciences, Special Matters and Government Investigations, Government Advocacy and Public Policy, and IP teams to provide a 360° defense. 

We successfully litigate, try and resolve high-value, brand threatening product liability cases; help clients navigate the FDA approval process and bring products to market; and represent biotechnology and pharmaceutical clients in obtaining, prosecuting, and defending patents

The team is led by Fritz Zimmer, a nationally recognized products liability trial attorney and tightly-controlled Type I diabetic who is actively involved in the ADA (including serving on the ADA National Finance Committee). His successful management of the disease and knowledge of leading experts in the field is unsurpassed.  Fritz’s personal insight and hands on experience with the science, products at issue, and claims made in litigation surrounding diabetes has been a benefit to many clients.